Published in J Clin Psychiatry on September 01, 2004
Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br J Psychiatry (2014) 3.28
Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom (2009) 1.79
A model of placebo response in antidepressant clinical trials. Am J Psychiatry (2013) 1.46
Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome. Curr Psychiatry Rev (2010) 1.38
Placebo and the new physiology of the doctor-patient relationship. Physiol Rev (2013) 1.20
Lessons learned from placebo groups in antidepressant trials. Philos Trans R Soc Lond B Biol Sci (2011) 1.17
Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact. J Am Acad Child Adolesc Psychiatry (2011) 1.04
A randomized, prospective pilot study of patient expectancy and antidepressant outcome. Psychol Med (2012) 1.03
Preference in random assignment: implications for the interpretation of randomized trials. Adm Policy Ment Health (2009) 0.96
A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci (2009) 0.93
Antidepressant study design affects patient expectancy: a pilot study. Psychol Med (2009) 0.91
How can placebo effects best be applied in clinical practice? A narrative review. Psychol Res Behav Manag (2015) 0.89
The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder. Behav Res Ther (2011) 0.88
Study design affects participant expectations: a survey. J Clin Psychopharmacol (2009) 0.88
Identifying risk for attrition during treatment for depression. Psychother Psychosom (2009) 0.86
Patients' treatment expectancies in clinical trials of antidepressants versus psychotherapy for depression: a study using hypothetical vignettes. Compr Psychiatry (2012) 0.83
Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study. J Clin Biochem Nutr (2013) 0.83
[Placebo response - Mechanisms and clinical applications]. Schmerz (2016) 0.81
The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill. J Eval Clin Pract (2009) 0.81
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials. Am J Psychiatry (2016) 0.80
Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis. J Affect Disord (2012) 0.78
Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder. J Psychiatr Res (2016) 0.77
A Randomized Survey of the Public's Expectancies and Willingness to Participate in Clinical Trials of Antidepressants Versus Psychotherapy for Depression. Prim Care Companion CNS Disord (2016) 0.75
The prediction of treatment outcomes by early maladaptive schemas and schema modes in obsessive-compulsive disorder. BMC Psychiatry (2014) 0.75
Psychiatrists' Attitudes Toward Non-Pharmacologic Factors Within the Context of Antidepressant Pharmacotherapy. Acad Psychiatry (2015) 0.75
Patient Pre-Treatment Expectations Do Not Predict Cocaine Use Outcomes: Data From Four Clinical Trials. Subst Use Misuse (2016) 0.75
Common Factors in Pediatric Psychiatry: A Review of Essential and Adjunctive Mechanisms of Treatment Outcome. J Child Adolesc Psychopharmacol (2016) 0.75
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology (2013) 2.62
Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety (2012) 2.23
Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med (2007) 2.22
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods (2011) 1.49
A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatr Serv (2002) 1.48
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol (2010) 1.29
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res (2009) 1.18
Biomarkers to predict antidepressant response. Curr Psychiatry Rep (2010) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav (2011) 1.11
fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res (2010) 1.10
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res (2009) 1.09
A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. J Clin Psychiatry (2015) 1.07
Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology (2002) 1.06
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res (2005) 1.05
Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am (2011) 1.04
Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry (2004) 1.04
Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol (2004) 1.03
Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav (2013) 1.02
Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol (2009) 1.01
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol (2002) 0.98
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry (2006) 0.96
Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv (2005) 0.93
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) (2004) 0.93
A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci (2009) 0.93
White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci (2002) 0.93
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol (2003) 0.92
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci (2013) 0.92
Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res (2009) 0.92
Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry (2010) 0.91
Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril (2006) 0.91
A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res (2013) 0.90
Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety (2013) 0.90
Does the clinical course of depression determine improvement in symptoms and quality of life? J Nerv Ment Dis (2006) 0.89
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol (2009) 0.89
Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr (2008) 0.89
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry (2005) 0.87
Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One (2012) 0.87
Relationship between medical student perceptions of mistreatment and mistreatment sensitivity. Med Teach (2012) 0.86
Baroreflex mechanisms in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.86
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry (2014) 0.86
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am (2007) 0.86
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics (2005) 0.85
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol (2010) 0.85
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav (2013) 0.85
Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry (2007) 0.84
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res (2011) 0.82
Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci (2008) 0.81
Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl) (2015) 0.81
Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am (2014) 0.80
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology (2005) 0.80
Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Ann N Y Acad Sci (2015) 0.80
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci (2009) 0.80
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci (2013) 0.79
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry (2002) 0.79
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology (2014) 0.79
Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas (2006) 0.79
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol (2010) 0.79
Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: a preliminary study. J Sex Med (2010) 0.79
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry (2013) 0.79